#USA #Plantation #Leadership Change #Akumin #Henry Howe

Akumin Welcomes New Leadership Under Henry Howe

On March 31, 2025, Akumin Inc., a prominent player in the U.S. healthcare sector specializing in outpatient radiology and oncology services, made a significant leadership change by appointing Henry Howe as its new Chief Executive Officer. This strategic decision aims to steer the company towards future growth and operational excellence. Howe succeeds Krishna Kumar, who has been instrumental in Akumin's progress.

A Strong Addition to the Akumin Team

Henry Howe brings a wealth of experience to Akumin. His most recent role was as interim CEO and Chief Financial Officer at Envision Healthcare Corporation, a major national medical group focusing on hospital-based specialties. His previous tenure at Bridgewater Associates involved various leadership positions, including Head of Planning. Additionally, Howe's background includes over six years at Bain & Company, where he provided strategic and operational counsel across multiple sectors.

Bill Theofilou, Chairman of the Board, expressed his pride in Akumin's recent accomplishments while acknowledging that the timing is right for new leadership. He stated, "We look forward to benefiting from Henry's expertise and experience as we position the company for long-term success by focusing on quality patient care and operational excellence for our partners and our people."

Commitment to Excellence

Upon his appointment, Howe expressed his enthusiasm for joining Akumin, emphasizing the company's commitment to delivering vital outpatient radiology and oncology services to health systems, hospitals, and patients nationwide. He stated, "Akumin has a robust foundation in place, and I am confident that we will continue to build on this momentum. I look forward to collaborating with our talented team to provide exceptional services to patients and healthcare providers."

Juan Perez, Akumin's Chief Financial Officer, will step down in 2025 but remain in his role until the Board identifies his successor. The leadership transitions reflect Akumin's commitment to adapting and innovating in a rapidly evolving healthcare landscape.

Akumin's Vision and Operational Excellence

As a leader in advanced imaging and radiation oncology in the United States, Akumin is renowned for handling the highest volume of MRI and PET-CT scans among healthcare providers. With partnerships with over 1,000 healthcare providers—23 of the top 30 health systems included—Akumin has shown its ability to enhance patient access and care standards. The company prides itself on its combination of informatics and clinical expertise, aiming to meet the ever-changing demands of the healthcare sector.

By focusing on innovations and collaborations, Akumin is dedicated to pioneering the future of patient-centered care. The company’s mission centers on improving healthcare delivery and ensuring that patients receive the highest quality services. As Akumin embarks on this new chapter under Henry Howe's leadership, stakeholders are optimistic about the company's trajectory and performance.

For those interested in learning more about Akumin and its services, further details can be found at www.akumin.com. The future appears bright as the company embraces new leadership to tackle the challenges and opportunities that lie ahead.